000 01334 a2200337 4500
005 20250516131633.0
264 0 _c20140122
008 201401s 0 0 eng d
022 _a1432-2013
024 7 _a10.1007/s00424-013-1216-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKuruppu, Sanjaya
245 0 0 _aEndothelin-converting enzyme-1 inhibition and renoprotection in end-stage renal disease.
_h[electronic resource]
260 _bPflugers Archiv : European journal of physiology
_cJul 2013
300 _a929-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAspartic Acid Endopeptidases
_xantagonists & inhibitors
650 0 4 _aChymases
_xmetabolism
650 0 4 _aEndothelin-Converting Enzymes
650 0 4 _aEndothelins
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xdrug therapy
650 0 4 _aMetalloendopeptidases
_xantagonists & inhibitors
650 0 4 _aNeprilysin
_xmetabolism
700 1 _aRajapakse, Niwanthi W
700 1 _aSmith, A Ian
773 0 _tPflugers Archiv : European journal of physiology
_gvol. 465
_gno. 7
_gp. 929-34
856 4 0 _uhttps://doi.org/10.1007/s00424-013-1216-1
_zAvailable from publisher's website
999 _c22428084
_d22428084